Thermo fisher's ngs assay receives fda approval as a companion diagnostic for zegfrovy and for tumor profiling

Carlsbad, calif.--(business wire)--thermo fisher scientific, the world leader in serving science, today announced the u.s. food and drug administration (fda) has approved the oncomine™ dx express test on the ion torrent™ genexus™ dx integrated sequencer as an in vitro diagnostic (ivd) assay for use as a companion diagnostic (cdx) for dizal's zegfrovy® (sunvozertinib) and in tumor profiling. this approval brings rapid next-generation sequencing (ngs) to decentralized clinical settings closer to.
TMO Ratings Summary
TMO Quant Ranking